Our
Background

Cann Pharmaceutical (Cann Pharma) was the first Australian company to obtain a joint venture with a licensed medicinal cannabis company in Israel.

The founder of second licensed producer better™ helped shape the Israeli industry. As a result, better™ and Cann Pharma has a market leading position in Australia with existing medicinal grade cannabis products able to be recommended by physicians for 16 medical diseases and conditions.

better™ has ten years of licensed experience in Israel and is one of few 100% organic, chemical free, global producers of phytocannabinoid products.

better™ has established a world leading position in the development of plant-derived cannabinoid therapeutics via its research and development and intellectual property portfolio.

This standardised, proprietary growing system and agri-med technology and ongoing research and development created medicinal products for 16 different illnesses and disease provides Cann Pharma with a lead time over other companies.

Our lead product is the Cannabidiol (CBD) Enriched Oil treatment EP1 for drug resistant epilepsy (DRE) in children, adolescents and adults. EP1 has been through a two year clinical trial in Israel and is an approved treatment for patients and medical practitioners for refractory epilepsy.

Cann Pharma has a pathway for patients to derive access to EP1 in Australia and overseas markets.

Cann Pharma has large territories and export markets and globalisation rights to novel phytocannabinoid products from our clinical studies pipeline in Australia.

We will also create new cannabinoid medicines from our deep pipeline of clinical studies – that address unmet patient needs.

better™ currently operates a greenhouse cultivation facility in Israel and a new greenhouse facility in the Czech Republic, producing proven organic medical grade cannabis products.

Together, better™ and Cann Pharma are leaders in the medicinal cannabinoid sector:

  • Proven treatments (16 medical conditions)
  • Recommended by physicians today
  • Used by patients every day – over 12,000
  • Successful clinical trials
  • 100% organic cultivation & production
  • Greater than 5 years experience

We draw on these developed systems and protocols developed in Israel for over 10 years in Israel that will produce 100% organic medicinal grade cannabis and pharmaceutical products with proven safety and medical efficacy.